Fall 2023 Vol. 13 Issue 03
-
From the Editor-in-Chief
Immunotherapy Gets PersonalTherapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
The Art of DeflectionCasual conversations can take unwelcome turns after you’ve been diagnosed with cancer. Here’s how to respond when people say the wrong things.
by Hester Hill Schnipper
-
Caregiving With Confidence
Addressing AngerCaregivers can take steps to encourage patients to have more healthy dialogue about strong emotions.
by K.J. Bannan
-
Policy Matters
Clinical Trials That Reflect Real-world PatientsA recent article discusses challenges and practical solutions for working toward more diverse and equitable oncology clinical trials.
by Nicholas Warren, PhD
-
Immunotherapy: When Is Sooner Better Than Later?
Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Making Clinical Trials Easier
Clinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.
by Cameron Walker
-
Survivor Profile
Changing CourseInitially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
Q&A
Pulling Back the Research CurtainJessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
Get Involved
A Bountiful HarvestFood for the Cure provides fresh produce to people with cancer.
by Thomas Celona
-
Facts and Stats
Will We Make the Moonshot?As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff